Starting or Switching to an Integrase Inhibitor-Based Regimen Affects PTSD Symptoms in Women with HIV

BACKGROUND: As the use of Integrase inhibitor (INSTI)-class antiretroviral medications becomes more common to maintain long-term viral suppression, early reports suggest the potential for CNS side-effects when starting or switching to an INSTI-based regimen. In a population already at higher risk fo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AIDS Behav
Main Authors: Kamkwalala, Asante R., Wang, Kunbo, O’Halloran, Jane, Williams, Dionna W., Dastgheyb, Raha, Fitzgerald, Kathryn C., Spence, Amanda B., Maki, Pauline M., Gustafson, Deborah R., Milam, Joel, Sharma, Anjali, Weber, Kathleen M., Adimora, Adaora A., Ofotokun, Igho, Sheth, Anandi N., Lahiri, Cecile D., Fischl, Margaret A., Konkle-Parker, Deborah, Xu, Yanxun, Rubin, Leah H.
Formato: Artigo
Idioma:Inglês
Publicado: 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948485/
https://ncbi.nlm.nih.gov/pubmed/32638219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10461-020-02967-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares